Publications by authors named "Shiyang Ning"

Claim this Profile
I
Identification of S100A9 as a target for diagnosis and treatment of Crohn's Disease after Vedolizumab treatment failure.
Yanru Zhang, Zhe Zhang, Ruixian Liu, Yijia He, Shiyang Ning

Immunol Lett· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Ddx21 mutant peptide is an effective neoantigen in prophylactic lung cancer vaccines and activates long-term anti-tumor immunity.
Zhe Zhang, Yimeng Xia, Zhihong Wang, Yaxing Sun, Dan Pu, Shiyang Ning

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitior of Bcl6 by FX1 protects DSS induced colitis mice through anti-inflammatory effects.
Ruixian Liu, Zhe Zhang, Chuan Zhou, Binbin Wang, Muhan Zhang, Shiyang Ning

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-talk between macrophages and gut microbiota in inflammatory bowel disease: a dynamic interplay influencing pathogenesis and therapy.
Shiyang Ning, Zhe Zhang, Chuan Zhou, Binbin Wang, Zhanju Liu

Front Med (Lausanne)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis